Patient characteristics in pediatric eosinophilic esophagitis in Dupilumab and non Dupilumab treated cohorts 🔗 Access full article via Journal of Allergy and Clinical ImmunologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
